Clinical Trial Detail

NCT ID NCT02110069
Title A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati, Pfizer
Indications
Therapies

Vincristine Sulfate

Sirolimus

Age Groups: child adult

No variant requirements are available.